Hot Undervalued Stocks To Watch For 2019

It has been a while since I updated my thoughts on Nektar Therapeutics (NKTR), and a lot has happened with this biotech over the past year, including a huge development deal with Bristol-Myers (BMY), mixed trial data at ASCO, and ongoing progress with additional compounds in the oncology pipeline. On top of all that, Nektar has a pain asset with potentially impressive upside, an exciting early-stage anti-inflammatory asset, and a significant amount of cash.

Nektar shares sold off hard after the disappointing ASCO results, but have since recovered 40%. At this price, I don’t necessarily think Nektar is seriously undervalued relative to the development risk. That’s a key caveat, though, as better clinical data on the NKTR-214 (or ‘214) melanoma program at the November SITC could restore some bullishness here and there is a lot of potential value in ‘214, NKTR-358, NKTR-262, and NKTR-255 that could be unlocked with future clinical successes.

A Year Later, ‘214 Is Still A Key Unknown

Clearly, the biggest driver for Nektar over the past year has been the rise and partial fall of expectations for ‘214, the company’s proprietary engineered IL-2 conjugate that could become a potent addition to immuno-oncology (or IO) combos. As I’ve written before, the IL-2 concept was validated long ago, but the use of it has been restricted by awful side-effects. While ‘214 showed rather unimpressive results as a monotherapy (something that does concern me…), the safety data have been very encouraging.

Hot Undervalued Stocks To Watch For 2019: MiMedx Group, Inc(MDXG)

Advisors’ Opinion:

  • [By Todd Campbell]

    After an internal audit of its accounting practices discovered problems that will force the company to restate five years’ worth of financial records, MiMedx Group (NASDAQ:MDXG) shareholders were dealt more bad news today when Blue Cross/Blue Shield parent Health Care Service Corp. announced it will no longer cover the company’s injectable amniotic-tissue products. The news sent shares tumbling 11.1% today.

  • [By Paul Ausick]

    MiMedx Group Inc. (NASDAQ: MDXG) fell more than 40% Monday to post a new 52-week low of $3.80. Shares closed at $6.39 on Friday. The 52-week high is $18.25. Volume of nearly 12 million was almost five times the daily average. The company’s CEO and COO both resigned this morning.

  • [By Cory Renauer]

    Shares of MiMedx Group, Inc. (NASDAQ:MDXG), a biopharmaceutical company with a hand in the tissue repair market, rose 16.6% in September, according to data from S&P Global Market Intelligence. Investors are beginning to like the business again, following the unpaid departure of key executives and a reprieve from the Nasdaq exchange.

  • [By Paul Ausick]

    MiMedx Group Inc. (NASDAQ: MDXG) dropped about 9.9% Tuesday to post a new 52-week low of $3.01. Shares closed at $3.34 on Monday and the stock’s 52-week high is $18.25. Volume totaled about 30% above the daily average of around 3 million. The company had no specific news.

  • [By Peter Graham]

    Small cap regenerative biomaterial product and bioimplant stock MiMedx Group Inc (NASDAQ: MDXG) is the thirteenth most shorted stock on the NASDAQ with short interest of 40.54% according to Highshortinterest.com. MiMedx Group is a leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing proprietary PURION® Process among other processes, to produce safe and effective allografts. MiMedx Group is the leading supplier of placental tissue, having supplied over 1,000,000 allografts to date for application in the Wound Care, Burn, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare.

Hot Undervalued Stocks To Watch For 2019: NO Name(ACI)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Before the bell, the U.S. Bureau of Economic Analysis reported its second GDP estimate for the fourth quarter. U.S. economic growth came in at 2.6%, a figure that topped consensus expectations. Q2 and Q3 2018 GDP growth came in at fabulous levels – 4.2% and 3.4%, respectively. However, investors predicted the reading would come in lower due to the government shutdown during the fourth quarter. In other economic news, the Department of Labor this morning reported weekly jobless claims at 225,000. That figure is slightly higher than the 220,000 expected by economists. The price of Bitcoin is currently hovering just under $4,000. We’ve been watching a long process of consolidation at these levels for several weeks. Despite short-term pain in the markets, Money Morning’s David Zeiler outlines the bullish case for Bitcoin. How high can the price of Bitcoin go? David makes the bullish case that Bitcoin could hit $250,000 by 2025. For more on how to profit from Bitcoin’s next bull cycle, go here now.
    Stocks to Watch Today: JCP, JWN, ACI, BUD
    Shares of J.C. Penney Co. Inc. (NYSE: JCP) popped more than 16% after the embattled retail giant reported earnings. The company topped Wall Street expectations and announced plans to shutter another 18 department stores this year. The company’s balance sheet temporarily improved after it was able to reduce its massive inventory glut. The firm reported EPS of $0.18, topping forecasts by $0.08. Revenue came in at $3.79 billion. Shares of Anheuser Busch Inbev NV (NYSE: BUD) popped more than 5% after the beer brewing giant crushed Wall Street earnings expectations. The Budweiser and Corona maker announced plans to increase its non-alcoholic and low-alcohol drinks business, two areas that continue to show impressive and rising global demand. The Western Union Co. (NYSE: WU) is generating buzz after it announced a $1 billion stock buyback program. In addition, the payment giant said it would sell its Speedpay bill paying bu

Hot Undervalued Stocks To Watch For 2019: Cooper Tire & Rubber Company(CTB)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Cooper Tire & Rubber Co (NYSE:CTB) – Stock analysts at Jefferies Financial Group cut their Q2 2019 earnings per share (EPS) estimates for shares of Cooper Tire & Rubber in a research report issued to clients and investors on Monday, August 6th. Jefferies Financial Group analyst B. Jordan now forecasts that the company will post earnings of $0.54 per share for the quarter, down from their previous forecast of $0.70.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Cooper Tire & Rubber (CTB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    ValuEngine downgraded shares of Cooper Tire & Rubber (NYSE:CTB) from a sell rating to a strong sell rating in a research report report published on Wednesday.

Hot Undervalued Stocks To Watch For 2019: Nestlé S.A. (NSRGF)

Advisors’ Opinion:

  • [By ]

    A year ago July, I recommended ASBFY a BUY along with Nestlé (OTCPK: NSRGY) (OTCPK: NSRGF). Briefly, ASBFY is

    A diversified international food, ingredients and retail group with sales of more than $32.6B operating in 50 countries on six continents Owner of brands including Mazola, Karo Syrup, Fleischmann Yeast, Durkee, Twinings Ovaltine, Tip Top Bakeries and more A huge producer of sugar and bioethanol fuels from China to Spain, and Africa’s largest sugar producer with factories in six countries A supplier of products and tech services to farmers, feed and food manufacturers, processors and retailers A producer of yeast and bakery ingredients operating plants in 32 countries and selling into 92 countries, plus it manufactures and markets enzymes, lipids, yeast extracts, and cereal specialties Primark is the ASBFY signature fashion chain with more than 300 stores in the UK and across Europe that bolsters ASBFY by accounting for half the company’s revenue and profit. Share Price Slump Is An Opportunity

    Shares last July were selling in the $39 range, rose to $45 close to November 2017, then began a slow but steady slide downhill opening August ’18 at just above $31. July 5, ’18 ASBFY announced “group revenue from continuing businesses for the 40 weeks ended 23 June 2018 was 3% ahead of the same period last year at constant currency and 2% ahead at actual exchange rates. Excluding Sugar, sales growth the developed from continuing businesses was 6% ahead of last year at constant currency and 5% ahead at actual exchange rates.” The grocery business pushed ahead 4% in the quarter with margins expected to increase for the full year. Ingredients revenue was up 4% and revenue from agriculture in the third quarter was +12% ahead of last year. Sales at Primark were +6% as sales space expanded.

Hot Undervalued Stocks To Watch For 2019: Shenandoah Telecommunications Co(SHEN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Shenandoah Telecommunications (SHEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Shenandoah Telecommunications (SHEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Shenandoah Telecommunications (SHEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Shenandoah Telecommunications (SHEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published. Required fields are marked *